Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial:

Prof Jaclyn A Smith, PhD Michael M Kitt, MD Alyn H Morice, MD Prof Surinder S Birring, MD Prof Lorcan P McGarvey, MD Prof Mandel R Sher, MD et al.

25 February, 2020

Respiratory Research Review Issue 179

Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia:

Catherine Ann Byrnes, Adrian Trenholme, Shirley Lawrence, Harley Aish, Julie Anne Higham, Karen Hoare, Aileen Elborough, Charissa McBride, Lyndsay Le Comte, Christine McIntosh, Florina Chan Mow, Mirjana Jaksic, Russell Metcalfe et al.

24 February, 2020

Respiratory Research Review Issue 179

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma :

Prof Jonathan A Bernstein, MD, Prof J Christian Virchow, MD, Kevin Murphy, MD, Jorge Fernando Maspero, MD, Joshua Jacobs, MD, Prof Yochair Adir, MD et al.

14 February, 2020

Respiratory Research Review Issue 176

Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study:

Kawsari Abdullah, Jingqin Zhu, Andrea Gershon, Sharon Dell, Teresa To

12 February, 2020

Respiratory Research Review Issue 176

Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction:

Augusto A. Litonjua, M.D., M.P.H., Vincent J. Carey, Ph.D., Nancy Laranjo, B.A., Benjamin J. Stubbs, B.A., Hooman Mirzakhani, M.D., Ph.D., George T. O’Connor, M.D., Megan Sandel, M.D., M.P.H., Avraham Beigelman, M.D., Leonard B. Bacharier, M.D., Robert S. Zeiger, M.D., Ph.D., Michael Schatz, M.D., Bruce W. Hollis, Ph.D., et al.

6 February, 2020

NZ Respiratory Research Review Issue 176

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial:

Harry J. de Koning, M.D., Ph.D., Carlijn M. van der Aalst, Ph.D., Pim A. de Jong, M.D., Ph.D., Ernst T. Scholten, M.D., Ph.D., Kristiaan Nackaerts, M.D., Ph.D., Marjolein A. Heuvelmans, M.D., Ph.D., Jan-Willem J. Lammers, M.D., Ph.D., Carla Weenink, M.D., Uraujh Yousaf-Khan, M.D., Ph.D., Nanda Horeweg, M.D., Ph.D., Susan van ’t Westeinde, M.D., Ph.D., Mathias Prokop, M.D., Ph.D., et al.

2 February, 2020

NZ Respiratory Research Review Issue 181

Effect of Olfactory Stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD:

Masashi Kanezaki, PT, PhD Kunihiko Terada, MD, PhD Satoru Ebihara, MD, PhD

22 January, 2020

NZ Respiratory Research Review Issue 180

Association Between Inhaled Corticosteroids and Tracheobronchomalacia:

Varun Shah, MD Bryan Husta, MD, FCCP Atul Mehta, MD, FCCP Byron Patton, MD Viera Lakticova, MD Suhail Raoof, MD, Master FCCP et al

21 January, 2020

NZ Respiratory Research Review Issue 180

A Geographic Analysis of Racial Disparities in Use of Pulmonary Rehabilitation After Hospitalization for COPD Exacerbation:

Kerry A. Spitzer, PhD, MPA Mihaela S. Stefan, MD, PhD Aruna Priya, MA, MSc Victor M. Pinto-Plata, MD Richard L. ZuWallack, MD Peter K. Lindenauer, MD et al

17 January, 2020

NZ Respiratory Research Review Issue 180

Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma:

Ingrid Maijers, Nethmi Kearns, James Harper, Mark Weatherall, Richard Beasley

2 January, 2020

Respiratory Research Review Issue 176